Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiling Lu

Showing results (111-120 of 224) with videos related to

Pageof 23
Sort By:
The Journal of Biological Chemistry|April 26, 2003
Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain lung cancer cell survivalHo-Young Lee, Harish Srinivas, Dianren Xia, et al.
Biochemical Pharmacology|November 3, 2009
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1Bo Hong, Vivian W Y Lui, Edwin P Hui, et al.
Cancer Research|April 6, 2006
Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemiaZhihong Zeng, Ismael J Samudio, Weiguo Zhang, et al.
Molecular & Cellular Proteomics : MCP|January 27, 2005
Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinomaKatherine M Sheehan, Valerie S Calvert, Elaine W Kay, et al.
Nature Cancer|September 3, 2024
A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependenciesJun Li, Wei Liu, Kamalika Mojumdar, et al.
NPJ Systems Biology and Applications|June 27, 2017
Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithmDaniel J McGrail, Curtis Chun-Jen Lin, Jeannine Garnett, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520Yun-Yong Park, Sang-Bae Kim, Hee Dong Han, et al.
The Journal of Clinical Investigation|November 5, 2019
A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosisXiaoyan Xu, Yumeng Wang, Kamalika Mojumdar, et al.
NPJ Breast Cancer|May 10, 2022
Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancersXuan Liu, Zhongqi Ge, Fei Yang, et al.
Cancer Cell|March 15, 2006
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineagesBarbara Visentin, John A Vekich, Bradley J Sibbald, et al.
Pageof 23

Showing results (111-120 of 224) with videos related to

Sort By:
Pageof 23
The Journal of Biological Chemistry|April 26, 2003
Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain lung cancer cell survivalHo-Young Lee, Harish Srinivas, Dianren Xia, et al.
Biochemical Pharmacology|November 3, 2009
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1Bo Hong, Vivian W Y Lui, Edwin P Hui, et al.
Cancer Research|April 6, 2006
Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemiaZhihong Zeng, Ismael J Samudio, Weiguo Zhang, et al.
Molecular & Cellular Proteomics : MCP|January 27, 2005
Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinomaKatherine M Sheehan, Valerie S Calvert, Elaine W Kay, et al.
Nature Cancer|September 3, 2024
A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependenciesJun Li, Wei Liu, Kamalika Mojumdar, et al.
NPJ Systems Biology and Applications|June 27, 2017
Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithmDaniel J McGrail, Curtis Chun-Jen Lin, Jeannine Garnett, et al.
Hepatology (Baltimore, Md.)|February 8, 2013
Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520Yun-Yong Park, Sang-Bae Kim, Hee Dong Han, et al.
The Journal of Clinical Investigation|November 5, 2019
A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosisXiaoyan Xu, Yumeng Wang, Kamalika Mojumdar, et al.
NPJ Breast Cancer|May 10, 2022
Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancersXuan Liu, Zhongqi Ge, Fei Yang, et al.
Cancer Cell|March 15, 2006
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineagesBarbara Visentin, John A Vekich, Bradley J Sibbald, et al.
Pageof 23